Search Results - "Contel, Maria"
-
1
Metal-based antibody drug conjugates. Potential and challenges in their application as targeted therapies in cancer
Published in Journal of inorganic biochemistry (01-10-2019)“…Antibody drug conjugates have emerged as a very attractive type of targeted therapy in cancer. They combine the antigen-targeting specificity of monoclonal…”
Get full text
Journal Article -
2
Encapsulation of Gold-Based Anticancer Agents in Protease-Degradable Peptide Nanofilaments Enhances Their Potency
Published in Journal of the American Chemical Society (11-01-2023)“…We investigated the use of amphiphilic, protease-cleavable peptides as encapsulation moieties for hydrophobic metallodrugs, in order to enhance their…”
Get full text
Journal Article -
3
Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma
Published in Cancer medicine (Malden, MA) (01-08-2019)“…Background There are few effective treatments for patients with advanced clear cell renal cell carcinoma (CCRCC). Recent findings indicate that ruthenium‐gold…”
Get full text
Journal Article -
4
Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer
Published in Chemistry : a European journal (21-06-2021)“…This review focuses on studies of coordination and organometallic compounds as potential chemotherapeutics against triple negative breast cancer (TNBC) which…”
Get full text
Journal Article -
5
Customizing Morphology, Size, and Response Kinetics of Matrix Metalloproteinase-Responsive Nanostructures by Systematic Peptide Design
Published in ACS nano (26-02-2019)“…Overexpression and activation of matrix metalloproteinase-9 (MMP-9) is associated with multiple diseases and can serve as a stimulus to activate nanomaterials…”
Get full text
Journal Article -
6
Potential Anticancer Heterometallic Fe–Au and Fe–Pd Agents: Initial Mechanistic Insights
Published in Journal of medicinal chemistry (25-07-2013)“…A series of gold(III) and palladium(II) heterometallic complexes with new iminophosphorane ligands derived from ferrocenylphosphanes [{Cp-P(Ph2)N-Ph}2Fe] (1),…”
Get full text
Journal Article -
7
Titanocene–Gold Complexes Containing N‑Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro
Published in Organometallics (09-05-2016)“…We report on the synthesis, characterization, and stability studies of new titanocene complexes containing a methyl group and a carboxylate ligand (mba =…”
Get full text
Journal Article -
8
Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties
Published in Journal of medicinal chemistry (13-08-2015)“…New organometallic gold(III) and platinum(II) complexes containing iminophosphorane ligands are described. Most of them are more cytotoxic to a number of…”
Get full text
Journal Article -
9
Unconventional Anticancer Metallodrugs and Strategies to Improve Their Pharmacological Profile
Published in Inorganics (01-07-2019)“…For the past 41 years, metal-based drugs have been widely used for the treatment of cancer [...]…”
Get full text
Journal Article -
10
Versatile synthesis of cationic N-heterocyclic carbene-gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents
Published in Chemical communications (Cambridge, England) (21-02-2016)“…We describe a versatile and quick route to cationic gold(i) complexes containing N-heterocyclic carbenes and a second ancillary ligand (such as phosphanes,…”
Get more information
Journal Article -
11
Frontispiece: Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer
Published in Chemistry : a European journal (21-06-2021)“…Triple negative breast cancer (TNBC) has one of the poorest prognoses and worst survival rates for patients, with chemotherapy still the gold standard for…”
Get full text
Journal Article -
12
In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer
Published in Journal of medicinal chemistry (11-12-2014)“…A series of organometallic ruthenium(II) complexes containing iminophosphorane ligands have been synthesized and characterized. Cationic compounds with…”
Get full text
Journal Article -
13
Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer
Published in European journal of medicinal chemistry (01-01-2019)“…Following promising recent in vitro and in vivo studies of the anticancer efficacies of heterometallic titanocene–gold chemotherapeutic candidates against…”
Get full text
Journal Article -
14
Organometallic Titanocene–Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties
Published in Organometallics (24-11-2014)“…Early–late transition metal TiAu2 compounds [(η-C5H5)2Ti{OC(O)CH2PPh2AuCl}2] (3) and new [(η-C5H5)2Ti{OC(O)-4-C6H4PPh2AuCl}2] (5) were evaluated as…”
Get full text
Journal Article -
15
Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand As Potential Anticancer Agents
Published in Organometallics (27-08-2012)“…The synthesis and characterization of a new water-soluble iminophosphorane ligand TPAN-C(O)-2BrC6H4 (1, C,N-IM; TPA = 1,3,5-triaza-7-phosphaadamantane) is…”
Get full text
Journal Article -
16
Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents
Published in Dalton transactions : an international journal of inorganic chemistry (28-06-2015)“…Two heterobimetallic complexes, i.e. [RuCl2(p-cymene)(μ-dppm)AuC] (1) and [RuCl2(p-cymene)(μ-dppm)Au(S-thiazoline)] (3), based on known cytotoxic…”
Get more information
Journal Article -
17
A heterometallic ruthenium–gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer
Published in Journal of biological inorganic chemistry (01-05-2018)“…Heterobimetallic compounds are designed to harness chemotherapeutic traits of distinct metal species into a single molecule. The ruthenium–gold (Ru–Au) family…”
Get full text
Journal Article -
18
A Bis(ortho-amine)aryl−Gold(I) Compound as an Efficient, Nontoxic, Arylating Reagent
Published in Organometallics (14-10-2002)“…A novel strategy for the synthesis of bis(ortho-amine)chelated monoanionic bisaminoaryl−metal complexes is presented. This method constitutes the exchange of a…”
Get full text
Journal Article -
19
Heterometallic titanium-gold complexes inhibit renal cancer cells in vitro and in vivo
Published in Chemical science (Cambridge) (01-09-2015)“…Following recent work on heterometallic titanocene-gold complexes as potential chemotherapeutics for renal cancer, we report here on the synthesis,…”
Get full text
Journal Article -
20
Titanocene–Phosphine Derivatives as Precursors to Cytotoxic Heterometallic TiAu2 and TiM (M = Pd, Pt) Compounds. Studies of Their Interactions with DNA
Published in Inorganic chemistry (07-11-2011)“…A series of tri- and bimetallic titanium–gold, titanium–palladium, and titanium–platinum derivatives of the general formulas [Ti{η5-C5H4(CH2) n…”
Get full text
Journal Article